REGN Regeneron Pharmaceuticals, Inc.

REGN Regeneron Pharmaceuticals, Inc.

Healthcare · Biotechnology

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 2 scans as of 2026-10-16 2 bull converging

POC $754.74 · VWAP $717.43 · +10.2% vs 12m avg buyer

uptrend vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster EVP, Director sold $2.3M, Sep 3

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

REGN Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist REGN belongs to, members best 30-day change first — REGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings REGN reports in 13 days Oct 30

Last report Jul 30

Reported the quarter ending 2026-06-30: revenue $4.29B, diluted EPS $12.23, net income $1.30B (SEC filing). Across the print the stock moved +9.7% (close before → first close after).

full note →

Against street estimates

How REGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 30 · projection Oct 16

Result
Jul 30 10.2114.29+40.0%Beat
Apr 29 8.909.47 GAAP ≠ +6.4%Beat
Jan 30 10.7511.44+6.4%Beat
Oct 28 '25 9.6411.83+22.7%Beat
Aug 1 '25 8.4412.89+52.7%Beat
Apr 29 '25 8.488.22-3.0%Miss
Feb 4 '25 11.1912.07+7.8%Beat
Oct 31 '24 11.7012.46+6.5%Beat

Recent news

Headlines about REGN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 1 day ago · Oct 16

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Jul 30 Catalyst REGN earnings
Apr 29 Catalyst REGN earnings